NCT01198912已完成2 期
Influence of Oral Doxycycline on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With and Without Nasal Polyposis: a Double-blind Randomized Placebo-controlled Trial.
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 33
- 试验地点
- 2
- 主要终点
- Endoscopic evaluation of quality and speed of wound healing
研究概览
简要总结
This is a randomized, double blind, placebo controlled, parallel group, study in patients with chronic rhinosinusitis with or without nasal polyps. The objective is to test the clinical efficacy of long-term low dose oral doxycycline on wound healing quality after endoscopic sinus surgery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •at least 18 years of age, of either sex and any race
- •diagnosis of chronic rhinosinusitis with or without nasal polyposis according to the EPOS guidelines research
- •Subjects should be regularly scheduled for bilateral functional endonasal endoscopic sinus surgery
- •Subjects must be in good health, free of any clinically significant disease that would interfere with the study schedule or procedures or compromise his/her safety.
- •Subjects must be willing to give informed consent and adhere to visit schedules, medication restrictions, and agree to perform daily diary entries.
- •Nonpregnant women of childbearing potential must use a medically acceptable, adequate form of birth control.
排除标准
- •Women must not be pregnant, breast feeding, or premenarcheal.
- •Subjects who have required oral corticosteroids within the previous four weeks prior to surgery.
- •Subjects who have required nasal corticosteroids within the previous one week prior to surgery.
- •Subjects with known allergic reaction on tetracyclines, diabetes (type 1 and 2), renal insufficiency, severe liver disease, systemic diseases affecting the nose (e.g. M. Wegener), prior surgeries of the paranasal sinuses.
- •Patients with the following diseases should be excluded :
- •Cystic fibrosis based on positive sweat test or DNA alleles
- •Gross immunodeficiency (congenital or acquired)
- •congenital mucociliary problems e.g. primary ciliary dyskinesia (PCD)
- •Non-invasive fungal balls and invasive fungal disease
- •systemic vasculitis and granulomatous diseases
- •Cocaine abuse
研究组 & 干预措施
placebo
Placebo Comparator
干预措施: placebo (Drug)
doxycycline 100 mg
Experimental
干预措施: doxycycline 100 mg (Drug)
结局指标
主要结局
Endoscopic evaluation of quality and speed of wound healing
时间窗: at 3 months after first drug intake
Recurrence of nasal polyps
时间窗: at 6 months after first drug intake
次要结局
- nasal and exhaled NO(at 6 months after first drug intake)
- inflammatory mediators in nasal fluid as well as in serum(at 6 months after first drug intake)
- subjective assessment of the wound healing(at 6 months after first drug intake)
- chronic rhinosinusitis symptoms by the patients(at 6 months after first drug intake)
- Questionnaires: SNOT 22, RSOM, SF36 asthma control questionnaire(at 6 months after first drug intake)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Effects of Doxycycline on Persistent Symptoms Post-neuroborreliosisFatigueRadicular PainCognitive DysfunctionParesthesiaParesisNCT01205464Linkoeping University15
已完成
不适用
Influence of Local Doxycycline on the Outcomes of Periodontal RegenerationPeriodontal DiseasesNCT05878353University of Turin, Italy60
进行中(未招募)
1 期
Influence of oral doxycycline on wound healing after endonasal endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyposis: a double-blind randomized placebo-controlled trial.Chronic rhinosinusitisEUCTR2009-017997-19-BEGhent University Hospital80
已完成
3 期
Effects of Long Term Antibiotic Therapy on Exacerbation Rate in Stable COPD PatientsChronic Obstructive Pulmonary Disease (COPD)NCT02305940Imperial College London222
撤回
不适用
Trial of the Use of Doxycycline After Rotator Cuff RepairRotator Cuff InjuryNCT02388477Milton S. Hershey Medical Center
